Centre For Clinical Research And Biostatistics (CCRB)

Back

1 Unique Trial Number (assigned by CCRB)

CUHK_CCT00076

2 Trial Registration Date

2005-09-21

i Registration Status

Retrospective

3 Secondary IDs

4 Source(s) of Funding

N/A

5 Primary Sponsor

Nil

6 Secondary Sponsor

Nil

Function

Please specify

7 Responsible Contact Person (public contact person for patients interested in participating)

i Name

Prof. Dennis SC Lam

ii Address

iii Phone

dennislam_cu_res@cuhk.edu.hk

iv Email

email

v Affiliation

vi Country

8 Research Contact Person (person to contact for scientific inquiries)

i Name

Prof. Dennis SC Lam

ii Address

iii Phone

dennislam_cu_res@cuhk.edu.hk

iv Email

email

v Affiliation

vi Country

9 Official Scientific Title of the Study

A Randomized Controlled Trial to Compare the Safety and Efficacy of Intravitreal Triamcinolone Versus Combined Triamcinolone and Grid Laser Versus Observation in the Treatment of Macular Edema Associated With Central Retina Vein Occlusion

10 Public Title

i Public Title in Chinese 研究名稱

11 Short Title (Optional)

12 Countries of Recruitment

13 Research Ethic Review

i Has the study received appropriate ethics approval?

Yes

ii When is the approval date?

2004-01-04

iii Full Name of IRB/IEC

Please specify

iv IRB/IEC approval reference number

14 Medical Condition Being Studied

Eye Diseases

15 Intervention

i Types of intervention

Procedure

Please specify

ii Description/ name of Intervention/article

Treatment of macular edema secondary to CRVO with ivTA with laser

iii Dosage form of the intervention

iv Dosage of the intervention

v Duration of the intervention

30 months

vi Frequency of the intervention

16 Comparative Treatments

i Description/ name of comparative treatments

Treatment of macular edema secondary to CRVO with ivTA without laser

ii Dosage form of the comparative treatments

iii Dosage of the comparative treatments

iv Duration of the comparative treatments

v Frequency of the comparative treatments

17 Key Inclusion and Exclusion Criteria

i Inclusion Criteria

Inclusion criteria: 1. Age of at least 18 years; 2. Visual acuity 20/50 or poorer; 3. Macular edema of at least 250£gm involving the fovea, as documented on optical coherent tomogram 4. Patients with best corrected visual acuity of better than 1.7 ETDRS logMar units; 5. Patients physically fit to receive laser photocoagulation or intravitreal injection; 6. Informed consent

ii Exclusion Criteria

iii Age Minimum

iv Age Maximum

v Gender

18 Study Type

19 Study Design

i Randomization

Randomized

Please specify

ii Nature of control

Placebo

iii Degree of masking

Open label

If Single-blind, who will be masked?

iv Group Assignment

Parallel

v Study Phase

Please specify

vi Study Objectives (Optional)

20 Anticipated trial start date

2005-01-15

21 Target Sample Size

300

22 Recruitment Status

Not Yet Recruiting

23 Primary Outcome

Best-corrected visual acuity (ETDRS chart)

24 Secondary Outcome

1. Macular edema 2. Intraocular pressure 3. Degree of cataract assessed clinically 4. To measure the level of vascular endothelial growth factor in the vitreous at the time of treatment

25 Study Information/Publication

i Study Information/Publication Available?

No

ii Link to Study Information/Publication

26 Last Update Date

2013-01-14

27 Primary Registry and Trial Identifying Number

28 Date of Registration in Primary Registry

* Legacy Fields

i Recruitment Information Available?

Yes

ii Link to Recruitment Information

None

Back

Trial History Detail on 2005-09-21